News | Heart Failure | September 05, 2017

Israeli Hospital Completes First Implant of CORolla Heart Failure Device

First implant of elastic device implanted in the left ventricle is completed on 72-year-old patient

Israeli Hospital Completes First Implant of CORolla Heart Failure Device

September 5, 2017 — Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from Israeli start-up company CorAssist in a 72-year-old diastolic heart failure patient.

There are several types of heart failure based on the mode of heart dysfunction. Diastolic heart failure occurs when the left ventricle fails to relax and adequately refill with blood, resulting in a high filling pressure, congestion and shortness of breath. Approximately half of heart failure patients suffer from diastolic heart failure. The incidence of diastolic heart failure increases with age and is common among women with hypertension, obesity and diabetes. There is currently no effective proven treatment for this condition.

CorAssist developed the CORolla, an elastic device that is implanted inside the left ventricle of the heart by a minimally invasive procedure on a beating heart. The device can improve cardiac diastolic function by applying direct expansion force on the ventricle wall to help the heart fill with blood. The CorAssist technology was invented by Yair Feld, M.D., Ph.D., a cardiologist at Rambam Health Care Campus, together with partners Yotam Reisner, M.D., Ph.D., and Shay Dubi, M.D., Ph.D.

Prof. Gil Bolotin, director of the Department of Cardiac Surgery, and Dr. Arthur Kerner, senior physician in the Interventional Cardiology Unit, recently led a multi-disciplinary team of cardiologists, heart surgeons and other Rambam medical professionals in the first clinical implantation surgery on the 72-year old Canadian man admitted specifically for this procedure.

When asked how and why he came to Rambam for the procedure, Robert MacLachlan explained that he had run out of treatment options in Canada for his diastolic heart failure. His wife had read about the CORolla implant on the Internet and contacted Dr. Karen Bitton Worms, head of research – Department of Cardiac Surgery at Rambam.  MacLachlan's cardiologist encouraged him to apply. Bolotin explained that while many potential applicants were interested in the procedure, no one wanted to be first.

The Israel Ministry of Health has authorized up to 10 clinical trials at Rambam in Israel to test the efficacy of cardiac catheterization for placement of the CORolla implant.

Watch a video animation demonstrating how the CORolla device works.

Read the related article “Device Technologies to Reduce Heart Failure Readmissions.”

Watch the VIDEO “Technologies to Reduce Heart Failure Readmissions.”

For more information: www.corassist.com

Related Content

News | Heart Failure

May 16, 2022 — The Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) and ...

Home May 16, 2022
Home
News | Heart Failure

May 16, 2022 — Right heart failure (RHF) continues to be a major source of morbidity and mortality following left ...

Home May 16, 2022
Home
News | Heart Failure

May 5, 2022 – Cardiovascular disease is a group of conditions that can arise from a lack of physical activity, poor diet ...

Home May 05, 2022
Home
Feature | Heart Failure | By Jean-Luc Boulnois, Ph.D.

The current standard of care for heart failure (HF) is guideline-directed medical therapy combined with device-based ...

Home May 04, 2022
Home
News | Heart Failure
April 27, 2022 – The contractile and elastic properties of the heart are finely tuned. This is a prerequisite for the ...
Home April 27, 2022
Home
News | Heart Failure

April 25, 2022 — Pfizer is voluntarily recalling five (5) lots of Accupril (Quinapril HCl) tablets distributed by Pfizer ...

Home April 25, 2022
Home
News | Heart Failure

April 20, 2022 – The Pulmonary Hypertension Association (PHA) joins more than 80 organizations around the world on ...

Home April 20, 2022
Home
News | Heart Failure

April 19, 2022 – What happens below the cellular level when the heart contracts and relaxes has long been unexplored ...

Home April 19, 2022
Home
News | Heart Failure
April 19, 2022 – New breakthrough research by a University of South Florida lab team describing how certain fats can ...
Home April 19, 2022
Home
News | Heart Failure
April 19, 2022 – It is estimated that about one in four adults worldwide has a liver condition that is a risk factor for ...
Home April 19, 2022
Home
Subscribe Now